Enliven Therapeutics (ELVN) Stock Chart & Stock Price History $29.41 -0.14 (-0.47%) (As of 01:50 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enliven Therapeutics Stock Price Performance5 Day Performance+6.95%1 Month Performance+7.65%3 Month Performance+36.36%6 Month Performance+19.64%Year-To-Date Performance+113.51%1 Year Performance+136.40% Receive ELVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…Greta Thunberg once called it “extremely dangerous, expensive, and time-consuming”. But now, even the High Priestess of Climate Change herself has realized the world cannot continue without this controversial “AI Keystone” technology. In fact, she’s rushing to embrace it. And she’s not the only one. Jeff Bezos just invested $130 million into it. Sam Altman, the face of AI, has put the largest investment he’s ever made into it — a cool $375 million.Watch this new investigative report here. ELVN Stock Chart for Thursday, November, 7, 2024 ELVN Chart by TradingView Enliven Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/06/2024$28.01$29.55+5.50%$29.65$28.65370,212 shs$1.40 billion11/05/2024$27.65$28.01+1.30%$28.04$27.38227,509 shs$1.32 billion11/04/2024$27.63$27.65+0.07%$28.09$27.45451,869 shs$1.31 billion11/01/2024$27.85$27.63-0.79%$28.38$26.91432,977 shs$1.31 billion10/31/2024$28.39$27.85-1.90%$29.05$27.76278,175 shs$1.32 billion10/30/2024$28.52$28.39-0.46%$29.01$28.00135,036 shs$1.34 billion Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/29/2024$28.66$28.52-0.49%$28.62$28.1599,413 shs$1.35 billion10/28/2024$28.81$28.66-0.52%$29.34$27.96239,528 shs$1.35 billion10/25/2024$28.98$28.81-0.59%$29.69$28.67134,347 shs$1.36 billion10/24/2024$28.97$28.98+0.03%$29.64$28.78175,380 shs$1.36 billion10/23/2024$28.98$28.97-0.03%$29.08$27.74268,517 shs$1.36 billion10/22/2024$28.87$28.98+0.38%$29.07$28.31196,879 shs$1.36 billion10/21/2024$29.00$28.87-0.45%$29.11$28.39109,263 shs$1.36 billion10/18/2024$28.02$29.00+3.50%$30.03$27.75430,082 shs$1.36 billion10/17/2024$28.12$28.02-0.36%$28.24$27.77115,367 shs$1.32 billion10/16/2024$27.82$28.12+1.08%$28.57$27.69175,182 shs$1.32 billion10/15/2024$27.75$27.82+0.25%$27.86$27.10119,001 shs$1.31 billion10/14/2024$27.91$27.75-0.57%$28.00$27.29508,624 shs$1.31 billion10/11/2024$26.97$27.91+3.49%$28.12$26.76168,779 shs$1.32 billion10/10/2024$28.21$26.97-4.40%$27.96$26.15255,173 shs$1.27 billion10/09/2024$28.01$28.21+0.71%$28.62$27.50376,144 shs$1.33 billion10/08/2024$27.45$28.01+2.04%$28.51$27.34174,035 shs$1.32 billion10/07/2024$27.53$27.45-0.29%$27.80$26.75139,225 shs$1.29 billion10/04/2024$25.51$27.53+7.92%$27.62$25.48353,127 shs$1.29 billion10/03/2024$25.30$25.51+0.83%$25.56$24.60308,043 shs$1.20 billion10/02/2024$26.00$25.30-2.69%$25.98$24.981.13 million shs$1.19 billion10/01/2024$25.54$26.00+1.80%$27.55$24.93849,423 shs$1.22 billion09/30/2024$24.13$25.54+5.84%$25.61$23.85831,789 shs$1.20 billion09/27/2024$24.12$24.13+0.04%$24.65$23.99226,702 shs$1.14 billion09/26/2024$24.23$24.12-0.45%$24.88$24.05101,119 shs$1.14 billion09/25/2024$24.07$24.23+0.66%$24.28$23.56116,258 shs$1.14 billion09/24/2024$23.57$24.07+2.12%$24.31$22.81227,282 shs$1.13 billion09/23/2024$23.19$23.57+1.64%$24.64$23.29355,273 shs$1.11 billion09/20/2024$23.07$23.19+0.52%$23.55$22.39747,384 shs$1.09 billion09/19/2024$21.76$23.07+6.02%$23.60$21.89249,019 shs$1.09 billion09/18/2024$21.47$21.76+1.35%$22.85$21.47143,973 shs$1.02 billion09/17/2024$22.38$21.47-4.07%$23.00$21.37147,495 shs$1.01 billion09/16/2024$22.32$22.38+0.27%$22.72$22.10106,328 shs$1.05 billion09/13/2024$22.33$22.32-0.04%$22.80$22.09146,692 shs$1.05 billion09/12/2024$23.07$22.33-3.21%$23.51$22.18103,074 shs$1.05 billion5 stocks that can double in 2024 (Ad)You still have time to access the 5 Stocks that Can Double in 2024 report for free.Download your free report today!09/11/2024$23.27$23.07-0.86%$23.24$22.6581,646 shs$1.09 billion09/10/2024$23.00$23.27+1.17%$24.18$22.42121,278 shs$1.09 billion09/09/2024$21.44$23.00+7.28%$23.43$21.66169,564 shs$1.08 billion09/06/2024$21.91$21.44-2.15%$22.08$21.38148,117 shs$1.01 billion09/05/2024$21.74$21.91+0.78%$22.22$21.50201,028 shs$1.03 billion09/04/2024$22.20$21.74-2.07%$22.52$21.61165,602 shs$1.03 billion09/03/2024$21.88$22.20+1.46%$23.00$21.65263,257 shs$1.05 billion09/02/2024$21.88$21.88$22.65$21.34137,500 shs$1.03 billion08/30/2024$22.22$21.88-1.53%$22.65$21.34137,597 shs$1.03 billion08/29/2024$22.40$22.22-0.80%$23.08$22.10138,358 shs$1.05 billion08/28/2024$22.56$22.40-0.71%$23.00$22.1979,048 shs$1.05 billion08/27/2024$22.93$22.56-1.61%$23.13$22.0196,391 shs$1.06 billion08/26/2024$23.00$22.93-0.30%$23.30$22.62132,354 shs$1.08 billion08/23/2024$22.90$23.00+0.44%$23.14$22.70123,392 shs$1.08 billion08/22/2024$23.67$22.90-3.25%$23.73$22.7385,885 shs$1.08 billion08/21/2024$22.30$23.67+6.14%$23.72$22.09118,693 shs$1.11 billion08/20/2024$23.53$22.30-5.23%$23.73$22.06130,660 shs$1.05 billion08/19/2024$23.71$23.53-0.76%$23.92$22.69140,925 shs$1.11 billion08/16/2024$23.77$23.71-0.25%$24.28$23.3695,396 shs$1.12 billion08/15/2024$21.80$23.77+9.04%$23.86$22.15195,873 shs$1.12 billion08/14/2024$21.52$21.80+1.30%$22.44$21.0396,269 shs$1.03 billion08/13/2024$21.32$21.52+0.94%$22.11$21.2180,975 shs$1.01 billion08/12/2024$21.33$21.32-0.05%$21.83$20.88145,344 shs$1.00 billion08/09/2024$21.72$21.33-1.80%$23.73$20.88193,827 shs$1.00 billion08/08/2024$21.67$21.72+0.23%$22.51$21.46126,404 shs$1.02 billion08/07/2024$21.93$21.67-1.19%$22.82$21.14172,318 shs$1.02 billion08/06/2024$22.11$21.93-0.81%$22.35$21.49136,438 shs$1.03 billion Related Companies Avadel Pharmaceuticals Stock Chart Intellia Therapeutics Stock Chart Delcath Systems Stock Chart Editas Medicine Stock Chart Fulcrum Therapeutics Stock Chart bluebird bio Stock Chart CRISPR Therapeutics Stock Chart Corcept Therapeutics Stock Chart BridgeBio Pharma Stock Chart Biohaven Stock Chart Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELVN) was last updated on 11/7/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.